Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Healthy female volunteers aged between 18 and 50 years requiring contraception
- Exclusion Criteria:
- • Pregnancy or lactation
- • Any conditions that might interfere with the outcome as well as all contraindications for OC use
About Bayer
Bayer is a global healthcare and life sciences company dedicated to advancing health and well-being through innovative research and development. With a strong commitment to improving patient outcomes, Bayer conducts clinical trials across various therapeutic areas, including oncology, cardiology, and women's health. The company leverages cutting-edge science and technology to develop breakthrough therapies, while adhering to the highest standards of ethical practices and regulatory compliance. Through collaboration with healthcare professionals and research institutions, Bayer aims to bring transformative solutions to the market, ultimately enhancing the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fulnek, , Czech Republic
Ostrava Zabreh, , Czech Republic
Plzen, , Czech Republic
Praha 10, , Czech Republic
Praha, , Czech Republic
Brignoles, , France
Dijon, , France
Honfleur, , France
Morlaix, , France
Muret, , France
Nevers, , France
Paris, , France
Quetigny, , France
Tarare, , France
Toulouse, , France
Neubiberg, Bayern, Germany
Nürnberg, Bayern, Germany
Fulda, Hessen, Germany
Hannover, Niedersachsen, Germany
Blankenburg, Sachsen Anhalt, Germany
Burg, Sachsen Anhalt, Germany
Magdeburg, Sachsen Anhalt, Germany
Magdeburg, Sachsen Anhalt, Germany
Dresden, Sachsen, Germany
Dresden, Sachsen, Germany
Döbeln, Sachsen, Germany
Leipzig, Sachsen, Germany
Leipzig, Sachsen, Germany
Gera, Thüringen, Germany
Kahla, Thüringen, Germany
Berlin, , Germany
Berlin, , Germany
Berlin, , Germany
Berlin, , Germany
Gera, , Germany
Kahla, , Germany
Patients applied
Trial Officials
Bayer Study Director
Study Director
Bayer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials